XVIVO Perfusion AB
7.10.2021 15:21:56 CEST | ACCESS Newswire | Press release
GOTHENBURG, SE / ACCESSWIRE / October 7, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)
Invitation to attend XVIVO's conference call regarding the presentation of the interim report July - September 2021. The presentation will be held in English.
Time: Thursday, October 21, 2021 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
https://onlinexperiences.com/Launch/QReg/ShowUUID=07001B8B-3391-4BA9-8F3E-BBE54EDF834E .
Phone numbers to the conference:
Sweden: +46 856642651 PIN: 13466713#
UK: +44 3333000804 PIN: 13466713#
US: +1 6319131422 PIN: 13466713#
Conference name: XVIVO Group Interim Report Q3, conference ID: EV00128347
Participants from XVIVO:
Dag Andersson, CEO
Kristoffer Nordström, CFO
The press release for XVIVO's interim report July-September 2021 will be released on October 21, 2021 at 7:30 a.m. CET.
Before the conference call, slides will be available at the company web page, https://www.xvivoperfusion.com/corporate/financial-presentations/earnings-calls/
October 7, 2021
Gothenburg
XVIVO Perfusion AB (publ)
For further information, please contact:
Dag Andersson, CEO, +46 76 643 30 31, e-mail: dag.andersson@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com
About Us
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.
Attachments
Conference call on Interim Report
SOURCE: XVIVO Perfusion AB
View source version on accesswire.com:
https://www.accesswire.com/667197/Conference-Call-on-Interim-Report
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Formerra Appoints Matt Borowiec as Chief Commercial Officer1.5.2026 15:00:00 CEST | Press release
CLEVELAND, OH / ACCESS Newswire / May 1, 2026 / Formerra, a leading distributor of performance materials, today announced the appointment of Matt Borowiec as Chief Commercial Officer (CCO). Borowiec will lead the company's commercial organization to support continued growth and global expansion while strengthening sales execution and customer success. Borowiec is a seasoned executive with over 25 years' experience in operations, commercial and P&L roles across resin manufacturing, specialty compounding, and distribution, including leadership roles at GE Plastics, PolyOne (now Avient), Transcendia, Celanese, and Kinsley Group. With this background, he is well positioned to lead Formerra's commercial strategy at this important time in the company's evolution. "Matt brings a unique combination of producer‑side and distribution experience that positions him well to strengthen alignment between our suppliers, customers, and commercial teams," said Tom Kelly, Chief Executive Officer at Forme
Global Experts call for Paradigm Shift in Medicine, Health and Education to Save Lives and Fight Escalating Health Crisis1.5.2026 14:48:00 CEST | Press release
INNSBRUCK, AUSTRIA / ACCESS Newswire / May 1, 2026 / A global consortium of 64 experts (72 entities, 5 continents) unveiled two coordinated consensus plus policy brief reports, outlining a science‑driven roadmap to confront escalating health crises and to tackle the growing burden of noncommunicable diseases (NCDs-including cardiovascular diseases, cancer, diabetes, etc.: 75% of global deaths; 82% in low-/middle income countries; 90% of all death in European region). The centerpiece is HEAL-Healthy Eating & Active Living, ideally whole‑food plant‑predominant/vegetarian-vegan diets & daily exercise outdoors/active mobility-as the minimum, first‑line standard in health and care. The authors urge immediate action on Prevention-over-Treatment and reforming education and human‑relevant science (drug failure rate from animal studies is 90-95%, and as high as 99.6% for Alzheimer disease), with a rapid shift from disease‑centered reaction to person‑centered, lifestyle‑first cure and care. Figu
Datavault AI and CyberCatch Announce Signing of Binding Letter of Intent for Datavault AI to Acquire CyberCatch to Accelerate AI-Driven, Quantum-Resistant Cyber Risk Mitigation Solutions1.5.2026 14:00:00 CEST | Press release
Strategic acquisition is anticipated to position Datavault AI to bring CyberCatch's AI-enabled cyber risk mitigation solution into Datavault AI's SanQtum-secured edge Graphics Processing Unit ecosystem, addressing a global information security market projected to reach $240 billion in 2026 (Gartner) CyberCatch's post-quantum cryptography conversion plan is also expected to position the combined company ahead of the AI-enabled "Q-Day" quantum-attack horizon, now compressed to as early as 2029 (Google) AI-enabled adversary attacks in 2025 rose 89% year-over-year while average eCrime breakout time fell to 29 minutes, a 65% increase in adversary speed compared to 2024, per CrowdStrike's 2026 Global Threat Report, and Google Quantum AI research has now compressed the timeline for cryptographically relevant quantum computing to as early as 2029. PHILADELPHIA, PA AND SAN DIEGO, CA / ACCESS Newswire / May 1, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider o
Securitas Healthcare Acquires ZulaFly(TM) to Advance Cloud-Based RTLS and Accelerate Innovation Across Healthcare1.5.2026 14:00:00 CEST | Press release
LINCOLN, NE / ACCESS Newswire / May 1, 2026 / Securitas Healthcare, a leading provider of real‑time visibility and protection solutions for the healthcare industry, is proud to announce the acquisition of ZulaFly, a healthcare‑focused Real‑Time Location System (RTLS) and staff safety technology company known for its modern, cloud‑based platform. ZulaFly's cloud-based RTLS platform delivers real-time visibility and actionable insights through a flexible, data-driven architecture. Built as a single SOC 2 Type II-compliant instance, ZulaFly offers an intuitive user experience, easy configuration, standardized data models, centralized analytics, and simplified system management. This approach enables healthcare organizations to deploy faster, gain insights sooner, and reduce long-term total cost of ownership (TCO). "This acquisition aligns with our focus and commitment to delivering best‑in‑class RTLS solutions across both cloud-based and on-premise options, keeping our healthcare clients
Datavault AI Schedules Conference Call to Discuss First Quarter 2026 Financial Results on Friday, May 15, 202630.4.2026 21:00:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / April 30, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset ("RWA") tokenization technologies, today announced that it will report financial results for its first quarter of 2026 prior to market open on Friday, May 15, 2026. Following the release, Datavault AI will host a conference call and live webcast on the same day, at 8:30 a.m. ET. Conference Call and Webcast Information Date: Friday, May 15, 2026, at 8:30 a.m. ET Participant Dial-in (US): 1-877-709-8150 Participant Dial-in (International): 1-201-689-8354 -- or Click HERE for participant International Toll-Free access numbers Webcast Access: Click Here Datavault AI CEO, Nathaniel Bradley, and CFO Brett Moyer, will be presenting. A replay of the webcast will be made available later in the day in the Investors/Presentations section of the Datavault AI website: Click Here About Datavau
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom